This was an open-label ( blinded assessor ) , parallel-group , randomized controlled trial that included RA patients aged @ to @ years , not on MTX , and having active disease ( Disease Activity Score for @ joints using @ variables -LSB- DAS@ ( @ ) -RSB- @ ) .